Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Siwo Life Technology is a specialized biotechnology firm dedicated to the advancement of automated, closed-loop manufacturing systems for the cell and gene therapy (CGT) sector. Headquartered in Shenzhen, the company develops integrated hardware and software solutions that automate critical steps in cell processing, including isolation, expansion, and formulation. Their flagship platforms are designed to meet stringent GMP requirements, offering a scalable alternative to traditional manual cleanroom processes. By providing these standardized systems, Siwo Life helps therapeutic developers reduce the risk of contamination, lower operational costs, and enhance the reproducibility of complex biologics. The company's technology supports a wide range of applications, including CAR-T, TCR-T, and stem cell therapies. Siwo Life serves as a key infrastructure partner for clinical-stage biotech companies and large-scale CDMOs globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Siwo Life Technology.